ICU Medical plans resale of 8,929 shares of stock

ICU Medical, Inc. (ICUI) has a planned resale of 8,929 shares of common stock, handled through Morgan Stanley Smith Barney LLC Executive Financial Services and listed on NASDAQ.

Rhea-AI Filing Summary

ICU Medical, Inc. (ICUI) has a planned resale of 8,929 shares of common stock, handled through Morgan Stanley Smith Barney LLC Executive Financial Services and listed on NASDAQ. The filing lists an aggregate market value of approximately $1,633,403.62 for these shares, compared with 25,007,038 shares of common stock outstanding. The shares relate to previously exercised options in May 2025 and equity awards (restricted stock and performance stock units) vesting on March 15, 2026, with an approximate sale date of August 11, 2026.

Key Figures

Shares to be sold: 8,929 shares Aggregate market value: $1,633,403.62 Shares outstanding: 25,007,038 shares +4 more

7 metrics

Shares to be sold 8,929 shares Common stock covered by the Form 144 resale notice

Aggregate market value $1,633,403.62 Value of the 8,929 ICUI shares proposed to be sold

Shares outstanding 25,007,038 shares ICU Medical common shares outstanding referenced in the filing

Approximate sale date 08/11/2026 Planned date for the resale of ICUI shares on NASDAQ

Option-related shares 596; 596; 610; 575 shares Shares from previously exercised options dated May 22–28, 2025

Restricted stock vesting 1,453 shares Restricted stock vesting under a registered plan on March 15, 2026

Performance stock units 5,099 shares Shares tied to performance stock units dated March 15, 2026

Key Terms

Form 144, Previously Exercised Options, Restricted Stock Vesting Under a Registered Plan, Performance Stock Units, +1 more

5 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Previously Exercised Options financial

"Common | 05/22/2025 | Previously Exercised Options | Issuer"

Restricted Stock Vesting Under a Registered Plan financial

"Common | 03/15/2026 | Restricted Stock Vesting Under a Registered Plan"

Performance Stock Units financial

"Common | 03/15/2026 | Performance Stock Units | Issuer"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

aggregate market value financial

"8929 | 1633403.62 | 25007038 | 08/11/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ICUI's Form 144 filing disclose?

The Form 144 for ICUI discloses a planned resale of 8,929 shares of common stock with an aggregate market value of about $1,633,403.62, to be sold on NASDAQ around August 11, 2026.

How many ICUI shares are planned for sale under this Form 144?

The filing reports a planned sale of 8,929 shares of ICU Medical common stock. These shares are tied to stock option exercises in May 2025 and restricted stock and performance stock unit vesting on March 15, 2026.

What is the aggregate market value of the ICUI shares in this Form 144?

The reported aggregate market value of the 8,929 ICUI shares is approximately $1,633,403.62. This reflects the value of the securities covered by the notice of proposed sale, rather than the company’s total market capitalization.

How many ICUI shares are outstanding compared to those being sold?

The filing lists 25,007,038 shares of ICUI common stock outstanding, versus 8,929 shares covered by the planned resale. This indicates the Form 144 transaction relates to a small portion of the total outstanding shares.

What types of ICUI equity awards are involved in this Form 144?

The Form 144 notes shares associated with previously exercised options, restricted stock vesting under a registered plan, and performance stock units vesting on March 15, 2026, all issued by ICU Medical as the issuer.

When were the ICUI options and awards underlying this Form 144 activity dated?

Related option exercises are dated May 22, 23, 27, and 28, 2025. Restricted stock and performance stock units are noted with a vesting date of March 15, 2026, ahead of the approximate sale date of August 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 04:33 PM Accepted by SEC EDGAR 08/11/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001727477
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ICU MEDICAL, INC.
SEC File Number	001-34634
Address of Issuer	951 Calle Amanecer San Clemente CALIFORNIA 92673
Phone	(949) 366-2183
Name of Person for Whose Account the Securities are To Be Sold	CHRISTIAN VOIGTLANDER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8929	1633403.62	25007038	08/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/22/2025	Previously Exercised Options	Issuer			596	05/22/2025	Cash
Common	05/23/2025	Previously Exercised Options	Issuer			596	05/23/2025	Cash
Common	05/27/2025	Previously Exercised Options	Issuer			610	05/27/2025	Cash
Common	05/28/2025	Previously Exercised Options	Issuer			575	05/28/2025	Cash
Common	03/15/2026	Restricted Stock Vesting Under a Registered Plan	Issuer			1453	03/15/2026	Not Applicable
Common	03/15/2026	Performance Stock Units	Issuer			5099	03/15/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christian Balceus Voigtlander
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)